Esker Therapeutics logo

Esker Therapeutics Funding & Investors

South San Francisco, CA

Esker is a precision medicines company looking to eliminate the “all-comers” approach that is seen with today’s treatments for people with autoimmune disease. Even with the innovation of the last decade, many patients continue to cycle through the approved therapies while continuing to look for the right therapy to alleviate the impact of their disease without life-impacting side effects. Esker leverages a precision analytics platform, powered by Foresite Labs, coupled with a team of experts with deep experience in precision medicine drug development and immunology, in order to create medicines that change the lives of people with autoimmune disease.

eskertx.com

Total Amount Raised: $529,000,000

Esker Therapeutics Funding Rounds

  • Series C

    $259,000,000

    Series C Investors

    Foresite Capital
    Samsara BioCapital
    venBio Partners
    Sr One
    Lilly Asia Ventures
    Cormorant Asset Management
    Matrix Capital Management
    ABG
    Omega Funds
    Piper Heartland Healthcare Capital
    HBM Healthcare Investments
    Nextech
  • Series B

    $200,000,000

    Series B Investors

    Matrix Capital Management
  • Series A

    $70,000,000

    Series A Investors

    Foresite Capital
Funding info provided by Diffbot.